Both IL-6 and TNF may inhibit the transcription of IRS-1 and glucose transporter (GLUT)-4 genes, thus reducing glucose transport and enhancing insulin resistance in obese patients [9]. The gene discussed is IL6; the disease is Insulin resistance.